|
Stock Analysis PRO New!
|
|
| Risk Assessment |
|
| Trading Strategy |
|
Red day on Monday for Hikma Pharmaceuticals plc. stock after losing 1.14%
(Updated on Nov 17, 2025)
The Hikma Pharmaceuticals plc. stock price fell by -1.14% on the last day (Monday, 17th Nov 2025) from $42.27 to $41.79. During the last trading day the stock fluctuated 0.579% from a day low at $41.55 to a day high of $41.79. The price has fallen in 6 of the last 10 days and is down by -12.76% for this period. Volume has increased on the last day by 475 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 587 shares were bought and sold for approximately $24.53 thousand.
The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $40.20 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -6.56% during the next 3 months and, with a 90% probability hold a price between $37.56 and $45.79 at the end of this 3-month period.
HKMPY Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, November 06, 2025, and so far it has risen 3.00%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Hikma Pharmaceuticals plc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $41.91 and $46.77. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Hikma Pharmaceuticals plc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Hikma Pharmaceuticals plc. stock
Hikma Pharmaceuticals plc. finds support from accumulated volume at $41.55 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.240 between high and low, or 0.579%. For the last week, the stock has had daily average volatility of 0.99%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (HKMPY) For The Upcoming Trading Day Of Tuesday 18th
For the upcoming trading day on Tuesday, 18th we expect Hikma Pharmaceuticals plc. to open at $41.71, and during the day (based on 14 day Average True Range), to move between $41.20 and $42.38, which gives a possible trading interval of +/-$1.18 (+/-2.86%) up or down from last closing price. If Hikma Pharmaceuticals plc. takes out the full calculated possible swing range there will be an estimated 2.86% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $41.55 (0.57%) than the resistance at $45.89 (9.81%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Hikma Pharmaceuticals plc. stock A Buy?
Hikma Pharmaceuticals plc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score:
-4.270
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on November 18, 2025 - $41.71 ( 0.192%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
HKMPY Performance
Trading levels for HKMPY
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 41.95 | 0.384% |
| R2 | 41.86 | 0.164% |
| R1 | 41.80 | 0.0280% |
| Price | 41.79 | |
| S1 | 41.62 | -0.412% |
| S2 | 41.56 | -0.547% |
| S3 | 41.47 | -0.767% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 49.04 | 17.35% |
| R2 | 47.74 | 14.24% |
| R1 | 45.89 | 9.81% |
| Price | 41.79 | |
| S1 | 41.55 | -0.574% |
| S2 | 40.98 | -1.95% |
| S3 | 40.57 | -2.91% |
HKMPY Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Aug 18, 2025 | Aug 18, 2025 | Sep 29, 2025 | $0.700 | 1.45% |
| 2 | Mar 21, 2025 | Mar 21, 2025 | May 12, 2025 | $0.94 | 1.75% |
| 3 | Aug 19, 2024 | Aug 19, 2024 | Sep 30, 2024 | $0.620 | 1.25% |
| 4 | Mar 21, 2024 | Mar 21, 2024 | May 13, 2024 | $0.92 | 1.84% |
| 5 | Aug 05, 2023 | Aug 11, 2023 | Sep 25, 2023 | $0.500 | 0.97% |
FAQ
Click here for our free guide on how to buy Hikma Pharmaceuticals plc. Stock.
Buy HKMPY